Skip to main content

Web Exclusives

FDA Approvals, In the News

FDA Approves Empliciti, a New Immune-Stimulating Therapy to Treat Multiple Myeloma

FDA Moves Quickly to Approve Easy-to-Use Nasal Spray to Treat Opioid Overdose

FDA Approves Ninlaro, New Oral Medication to Treat Multiple Myeloma

FDA Approves Darzalex for Patients with Previously Treated Multiple Myeloma

FDA Approves New Pill to Treat Certain Patients with Non—Small-Cell Lung Cancer

FDA Approves Cotellic as Part of Combination Treatment for Advanced Melanoma

FDA Approves Praxbind, the First Reversal Agent for the Anticoagulant Pradaxa

FDA Approves New Injectable Drug to Treat Schizophrenia

Vyvanse (Lisdexamfetamine Dimesylate): First FDA-Approved Drug for the Treatment of Adults with Binge-Eating Disorder

Ibrance (Palbociclib): First CDK4 and CDK6 Inhibitor FDA Approved for the Treatment of Postmenopausal Women with Metastatic Breast Cancer

Page 25 of 37
Results 241 - 250 of 362